New immune cell therapy tested for Tough-to-Treat cancers
Disease control
Completed
This early-stage study tested the safety and initial effects of a new combination immune cell therapy for patients with advanced solid tumors that have spread and no longer respond to standard treatments. The trial involved 9 participants and aimed to find a safe dose and treatme…
Phase: PHASE1 • Sponsor: Seoul Hospital • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC